The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome

{ 'indexed': {'date-parts': [[2023, 3, 14]], 'date-time': '2023-03-14T07:50:44Z', 'timestamp': 1678780244501}, 'reference-count': 61, 'publisher': 'Springer Science and Business Media LLC', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2021, 11, 25]], 'date-time': '2021-11-25T00:00:00Z', 'timestamp': 1637798400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}, { 'start': { 'date-parts': [[2021, 11, 25]], 'date-time': '2021-11-25T00:00:00Z', 'timestamp': 1637798400000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2022, 1]]}, 'DOI': '10.1007/s00296-021-05056-2', 'type': 'journal-article', 'created': { 'date-parts': [[2021, 11, 25]], 'date-time': '2021-11-25T17:02:46Z', 'timestamp': 1637859766000}, 'page': '101-113', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 4, 'title': 'The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed ' 'cohort of patients with Behçet’s syndrome', 'prefix': '10.1007', 'volume': '42', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-4774-9284', 'authenticated-orcid': False, 'given': 'Guzin', 'family': 'Ozcifci', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-8125-4808', 'authenticated-orcid': False, 'given': 'Tahacan', 'family': 'Aydin', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-2959-0978', 'authenticated-orcid': False, 'given': 'Zeynep', 'family': 'Atli', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-8977-5931', 'authenticated-orcid': False, 'given': 'Ilker Inanc', 'family': 'Balkan', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-8632-2825', 'authenticated-orcid': False, 'given': 'Fehmi', 'family': 'Tabak', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-4077-1374', 'authenticated-orcid': False, 'given': 'Mert', 'family': 'Oztas', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-2082-4715', 'authenticated-orcid': False, 'given': 'Yesim', 'family': 'Ozguler', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-9561-2282', 'authenticated-orcid': False, 'given': 'Serdal', 'family': 'Ugurlu', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-1952-1135', 'authenticated-orcid': False, 'given': 'Gulen', 'family': 'Hatemi', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-0253-8368', 'authenticated-orcid': False, 'given': 'Melike', 'family': 'Melikoglu', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-8914-9690', 'authenticated-orcid': False, 'given': 'Izzet', 'family': 'Fresko', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-6625-1652', 'authenticated-orcid': False, 'given': 'Vedat', 'family': 'Hamuryudan', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-4965-2918', 'authenticated-orcid': False, 'given': 'Emire', 'family': 'Seyahi', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2021, 11, 25]]}, 'reference': [ { 'key': '5056_CR1', 'unstructured': 'https://www.worldometers.info/coronavirus/#countries. Accessed 7 ' 'September 2021'}, { 'key': '5056_CR2', 'unstructured': 'https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkey-confirms-first-case-of-coronavirus/1761522. ' 'Accessed 11 March 2020'}, { 'issue': '11', 'key': '5056_CR3', 'doi-asserted-by': 'publisher', 'first-page': '3195', 'DOI': '10.1007/s10067-020-05334-7', 'volume': '39', 'author': 'C Ferri', 'year': '2020', 'unstructured': 'Ferri C, Giuggioli D, Raimondo V, L’Andolina M, Tavoni A, Cecchetti R, ' 'Guiducci S, Ursini F, Caminiti M, Varcasia G, Gigliotti P, Pellegrini R, ' 'Olivo D, Colaci M, Murdaca G, Brittelli R, Mariano GP, Spinella A, ' 'Bellando-Randone S, Aiello V, Bilia S, Giannini D, Ferrari T, Caminiti ' 'R, Brusi V, Meliconi R, Fallahi P, Antonelli A, COVID-19 & ASD Italian ' 'Study Group (2020) COVID-19 and rheumatic autoimmune systemic diseases: ' 'report of a large Italian patients series. Clin Rheumatol. ' '39(11):3195–3204. https://doi.org/10.1007/s10067-020-05334-7', 'journal-title': 'Clin Rheumatol.'}, { 'issue': '12', 'key': '5056_CR4', 'doi-asserted-by': 'publisher', 'first-page': '1544', 'DOI': '10.1136/annrheumdis-2020-218296', 'volume': '79', 'author': 'JL Pablos', 'year': '2020', 'unstructured': 'Pablos JL, Galindo M, Carmona L, Lledó A, Retuerto M, Blanco R, ' 'Gonzalez-Gay MA, Martinez-Lopez D, Castrejón I, Alvaro-Gracia JM, ' 'Fernández Fernández D, Mera-Varela A, Manrique-Arija S, Mena Vázquez N, ' 'Fernandez-Nebro A, RIER Investigators Group; RIER investigators group ' '(2020) Clinical outcomes of hospitalised patients with COVID-19 and ' 'chronic inflammatory and autoimmune rheumatic diseases: a multicentric ' 'matched cohort study. Ann Rheum Dis. 79(12):1544–1549. ' 'https://doi.org/10.1136/annrheumdis-2020-218296', 'journal-title': 'Ann Rheum Dis.'}, { 'issue': '10', 'key': '5056_CR5', 'doi-asserted-by': 'publisher', 'first-page': '803', 'DOI': '10.1046/j.1365-4362.2003.01893.x', 'volume': '42', 'author': 'G Azizlerli', 'year': '2003', 'unstructured': 'Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT, Kulaç M, Tunç R, ' 'Urgancioğlu M, Dişçi R (2003) Prevalence of Behçet’s disease in ' 'Istanbul. Turkey Int J Dermatol 42(10):803–806. ' 'https://doi.org/10.1046/j.1365-4362.2003.01893.x', 'journal-title': 'Turkey Int J Dermatol'}, { 'issue': '2', 'key': '5056_CR6', 'doi-asserted-by': 'publisher', 'first-page': '107', 'DOI': '10.1038/nrrheum.2017.208', 'volume': '14', 'author': 'H Yazici', 'year': '2018', 'unstructured': 'Yazici H, Seyahi E, Hatemi G, Yazici Y (2018) Behçet syndrome: a ' 'contemporary view. Nat Rev Rheumatol. 14(2):107–119. ' 'https://doi.org/10.1038/nrrheum.2017.208 (Epub 2018 Jan 3. Erratum in: ' 'Nat Rev Rheumatol. 2018 Jan 24;14 (2):119)', 'journal-title': 'Nat Rev Rheumatol.'}, { 'issue': '5', 'key': '5056_CR7', 'doi-asserted-by': 'publisher', 'first-page': '281', 'DOI': '10.1056/NEJM199002013220501', 'volume': '322', 'author': 'H Yazici', 'year': '1990', 'unstructured': 'Yazici H, Pazarli H, Barnes CG, Tüzün Y, Ozyazgan Y, Silman A, ' 'Serdaroğlu S, Oğuz V, Yurdakul S, Lovatt GE et al (1990) A controlled ' 'trial of azathioprine in Behçet’s syndrome. N Engl J Med 322(5):281–285. ' 'https://doi.org/10.1056/NEJM199002013220501 (PMID: 2404204)', 'journal-title': 'N Engl J Med'}, { 'issue': '3', 'key': '5056_CR8', 'doi-asserted-by': 'publisher', 'first-page': '348', 'DOI': '10.1093/rheumatology/kei165', 'volume': '45', 'author': 'C Mat', 'year': '2006', 'unstructured': 'Mat C, Yurdakul S, Uysal S, Gogus F, Ozyazgan Y, Uysal O, Fresko I, ' 'Yazici H (2006) A double-blind trial of depot corticosteroids in ' 'Behçet’s syndrome. Rheumatology (Oxford) 45(3):348–352. ' 'https://doi.org/10.1093/rheumatology/kei165 (Epub 2005 Nov 1 PMID: ' '16263779)', 'journal-title': 'Rheumatology (Oxford)'}, { 'issue': '8', 'key': '5056_CR9', 'doi-asserted-by': 'publisher', 'first-page': '2478', 'DOI': '10.1002/art.21231', 'volume': '52', 'author': 'I Tugal-Tutkun', 'year': '2005', 'unstructured': 'Tugal-Tutkun I, Mudun A, Urgancioglu M, Kamali S, Kasapoglu E, Inanc M, ' 'Gül A (2005) Efficacy of infliximab in the treatment of uveitis that is ' 'resistant to treatment with the combination of azathioprine, ' 'cyclosporine, and corticosteroids in Behçet’s disease: an open-label ' 'trial. Arthritis Rheum 52(8):2478–2484. ' 'https://doi.org/10.1002/art.21231 (PMID: 16052571)', 'journal-title': 'Arthritis Rheum'}, { 'issue': '9', 'key': '5056_CR10', 'doi-asserted-by': 'publisher', 'first-page': '1500', 'DOI': '10.1002/art.40531', 'volume': '70', 'author': 'G Emmi', 'year': '2018', 'unstructured': 'Emmi G, Vitale A, Silvestri E, Boddi M, Becatti M, Fiorillo C, Fabiani ' 'C, Frediani B, Emmi L, Di Scala G, Goldoni M, Bettiol A, Vaglio A, ' 'Cantarini L, Prisco D (2018) Adalimumab-based treatment versus ' 'disease-modifying antirheumatic drugs for venous thrombosis in Behçet’s ' 'Syndrome: a Retrospective Study of Seventy Patients With Vascular ' 'Involvement. Arthritis Rheumatol 70(9):1500–1507. ' 'https://doi.org/10.1002/art.40531 (Epub 2018 Jul 19 PMID: 29676522)', 'journal-title': 'Arthritis Rheumatol'}, { 'key': '5056_CR11', 'doi-asserted-by': 'publisher', 'first-page': '67', 'DOI': '10.1016/j.jaut.2015.06.005', 'volume': '62', 'author': 'H Vallet', 'year': '2015', 'unstructured': 'Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani ' 'C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, ' 'Marie I, Perard L, Bouillet L, Cohen F, Sene D, Schoindre Y, Lidove O, ' 'Le Hoang P, Hachulla E, Fain O, Mariette X, Papo T, Wechsler B, Bodaghi ' 'B, Rigon MR, Cacoub P, Saadoun D, French Behçet Network (2015) Efficacy ' 'of anti-TNF alpha in severe and/or refractory Behçet’s disease: ' 'Multicenter study of 124 patients. J Autoimmun 62:67–74. ' 'https://doi.org/10.1016/j.jaut.2015.06.005', 'journal-title': 'J Autoimmun'}, { 'issue': '11', 'key': '5056_CR12', 'doi-asserted-by': 'publisher', 'first-page': '2686', 'DOI': '10.1002/1529-0131(200111)44:11<2686::aid-art448>3.0.co;2-h', 'volume': '44', 'author': 'S Yurdakul', 'year': '2001', 'unstructured': 'Yurdakul S, Mat C, Tüzün Y, Ozyazgan Y, Hamuryudan V, Uysal O, Senocak ' 'M, Yazici H (2001) A double-blind trial of colchicine in Behçet’s ' 'syndrome. Arthritis Rheum 44(11):2686–2692. ' 'https://doi.org/10.1002/1529-0131(200111)44:11%3c2686::aid-art448%3e3.0.co;2-h ' '(PMID: 11710724)', 'journal-title': 'Arthritis Rheum'}, { 'issue': '5', 'key': '5056_CR13', 'doi-asserted-by': 'publisher', 'first-page': '542', 'DOI': '10.1007/s10165-009-0200-2', 'volume': '19', 'author': 'F Davatchi', 'year': '2009', 'unstructured': 'Davatchi F, Sadeghi Abdollahi B, Tehrani Banihashemi A, Shahram F, Nadji ' 'A, Shams H, Chams-Davatchi C (2009) Colchicine versus placebo in ' 'Behçet’s disease: randomized, double-blind, controlled crossover trial. ' 'Mod Rheumatol 19(5):542–549. https://doi.org/10.1007/s10165-009-0200-2 ' '(Epub 2009 Jul 14 PMID: 19597921)', 'journal-title': 'Mod Rheumatol'}, { 'issue': '8', 'key': '5056_CR14', 'doi-asserted-by': 'publisher', 'first-page': '1567', 'DOI': '10.1007/s11739-020-02427-8', 'volume': '15', 'author': 'B Yurttaş', 'year': '2020', 'unstructured': 'Yurttaş B, Oztas M, Tunc A, Balkan İİ, Tabak OF, Hamuryudan V, Seyahi E ' '(2020) Characteristics and outcomes of Behçet’s syndrome patients with ' 'Coronavirus Disease 2019: a case series of 10 patients. Intern Emerg Med ' '15(8):1567–1571. https://doi.org/10.1007/s11739-020-02427-8 (Epub 2020 ' 'Jul 9)', 'journal-title': 'Intern Emerg Med'}, { 'key': '5056_CR15', 'doi-asserted-by': 'publisher', 'first-page': '651715', 'DOI': '10.3389/fimmu.2021.651715', 'volume': '12', 'author': 'SN Esatoglu', 'year': '2021', 'unstructured': 'Esatoglu SN, Tascilar K, Babaoğlu H, Bes C, Yurttas B, Akar S, Pehlivan ' 'O, Akleylek C, Tecer D, Seyahi E, Yuce-Inel T, Alpay-Kanitez N, Bodakci ' 'E, Tekgoz E, Colak S, Bolek EC, Koca SS, Kalyoncu U, Icacan OC, Ugurlu ' 'S, Oz HE, Hamuryudan V, Hatemi G, Turkish Society for Rheumatology ' 'COVID-19 Registry Investigators (2021) COVID-19 among patients with ' 'inflammatory rheumatic diseases. Front Immunol. 12:651715. ' 'https://doi.org/10.3389/fimmu.2021.651715', 'journal-title': 'Front Immunol.'}, { 'issue': '5', 'key': '5056_CR16', 'doi-asserted-by': 'crossref', 'first-page': '47', 'DOI': '10.55563/clinexprheumatol/pmnqmf', 'volume': '132', 'author': 'I Mattioli', 'year': '2021', 'unstructured': 'Mattioli I, Bettiol A, Silvestri E, Urban ML, Palermo A, Fagni F, ' 'Malandrino D, Del Bianco A, Prisco D, Emmi G (2021) Prevalence and ' 'clinical course of SARS-CoV-2 infection in patients with Behçet’s ' 'syndrome. Clin Exp Rheumatol. 132(5):47–50 (Epub 2021 Jun 9. PMID: ' '34128795.)', 'journal-title': 'Clin Exp Rheumatol.'}, { 'key': '5056_CR17', 'doi-asserted-by': 'publisher', 'author': 'G Espinosa', 'year': '2020', 'unstructured': 'Espinosa G, Araujo O, Amaro S, Bodro M, Moreno PJ, Moreno R, Ugarte A, ' 'Cervera R (2020) COVID-19 and Behçet’s disease: clinical case series. ' 'Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217778', 'journal-title': 'Ann Rheum Dis', 'DOI': '10.1136/annrheumdis-2020-217778'}, { 'issue': '9', 'key': '5056_CR18', 'doi-asserted-by': 'publisher', 'first-page': 'e541', 'DOI': '10.1111/jdv.17325', 'volume': '35', 'author': 'CC Zouboulis', 'year': '2021', 'unstructured': 'Zouboulis CC, van Laar JAM, Schirmer M, Emmi G, Fortune F, Gül A, Kirino ' 'Y, Lee ES, Sfikakis PP, Shahram F, Wallace GR (2021) ' 'Adamantiades-Behçet’s disease (Behçet’s disease) and COVID-19. J Eur ' 'Acad Dermatol Venereol 35(9):e541–e543. ' 'https://doi.org/10.1111/jdv.17325', 'journal-title': 'J Eur Acad Dermatol Venereol'}, { 'key': '5056_CR19', 'unstructured': 'https://covid19asi.saglik.gov.tr/TR-77707/asi-uygulanacak-grup-siralamasi.html. ' 'Accessed 27 March 2021'}, { 'key': '5056_CR20', 'unstructured': 'https://covid19.saglik.gov.tr/TR-66301/covid-19-rehberi.html. Accessed ' '2020˗2021'}, { 'issue': '7', 'key': '5056_CR21', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.autrev.2020.102575', 'volume': '19', 'author': 'G Emmi', 'year': '2020', 'unstructured': 'Emmi G, Bettiol A, Mattioli I, Silvestri E, Di Scala G, Urban ML, Vaglio ' 'A, Prisco D (2020) SARS-CoV-2 infection among patients with systemic ' 'autoimmune diseases. Autoimmun Rev 19(7):102575. ' 'https://doi.org/10.1016/j.autrev.2020.102575', 'journal-title': 'Autoimmun Rev'}, { 'key': '5056_CR22', 'volume-title': 'Biostatistics: a foundation for analysis in the health sciences', 'author': 'WW Daniel', 'year': '1999', 'unstructured': 'Daniel WW (1999) Biostatistics: a foundation for analysis in the health ' 'sciences, 7th edn. Wiley, New York', 'edition': '7'}, { 'key': '5056_CR23', 'unstructured': 'https://covid19.saglik.gov.tr/TR-66935/genel-koronavirus-tablosu.html. ' 'Accessed September 2021'}, { 'key': '5056_CR24', 'unstructured': 'https://data.tuik.gov.tr/Bulten/Index?p=37210. Accessed September 2021'}, { 'issue': '9', 'key': '5056_CR25', 'doi-asserted-by': 'publisher', 'first-page': 'e557', 'DOI': '10.1016/S2665-9913(20)30227-7', 'volume': '2', 'author': 'J Zhong', 'year': '2020', 'unstructured': 'Zhong J, Shen G, Yang H, Huang A, Chen X, Dong L, Wu B, Zhang A, Su L, ' 'Hou X, Song S, Li H, Zhou W, Zhou T, Huang Q, Chu A, Braunstein Z, Rao ' 'X, Ye C, Dong L (2020) COVID-19 in patients with rheumatic disease in ' 'Hubei province, China: a multicentre retrospective observational study. ' 'Lancet Rheumatol 2(9):e557–e564. ' 'https://doi.org/10.1016/S2665-9913(20)30227-7', 'journal-title': 'Lancet Rheumatol'}, { 'key': '5056_CR26', 'doi-asserted-by': 'publisher', 'author': 'S Akiyama', 'year': '2020', 'unstructured': 'Akiyama S, Hamdeh S, Micic D, Sakuraba A (2020) Prevalence and clinical ' 'outcomes of COVID-19 in patients with autoimmune diseases: a systematic ' 'review and meta-analysis. Ann Rheum Dis. ' 'https://doi.org/10.1136/annrheumdis-2020-218946', 'journal-title': 'Ann Rheum Dis', 'DOI': '10.1136/annrheumdis-2020-218946'}, { 'issue': '10', 'key': '5056_CR27', 'doi-asserted-by': 'publisher', 'first-page': 'e698', 'DOI': '10.1016/S2665-9913(21)00151-X', 'volume': '3', 'author': 'YH Shin', 'year': '2021', 'unstructured': 'Shin YH, Shin JI, Moon SY, Jin HY, Kim SY, Yang JM, Cho SH, Kim S, Lee ' 'M, Park Y, Kim MS, Won HH, Hong SH, Kronbichler A, Koyanagi A, Jacob L, ' 'Smith L, Lee KH, Suh DI, Lee SW, Yon DK (2021) Autoimmune inflammatory ' 'rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide ' 'cohort study. Lancet Rheumatol 3(10):e698–e706. ' 'https://doi.org/10.1016/S2665-9913(21)00151-X', 'journal-title': 'Lancet Rheumatol'}, { 'issue': '8', 'key': '5056_CR28', 'doi-asserted-by': 'publisher', 'first-page': '1229', 'DOI': '10.1007/s00296-020-04626-0', 'volume': '40', 'author': 'E Seyahi', 'year': '2020', 'unstructured': 'Seyahi E, Poyraz BC, Sut N, Akdogan S, Hamuryudan V (2020) The ' 'psychological state and changes in the routine of the patients with ' 'rheumatic diseases during the coronavirus disease (COVID-19) outbreak in ' 'Turkey: a web-based cross-sectional survey. Rheumatol Int ' '40(8):1229–1238. https://doi.org/10.1007/s00296-020-04626-0', 'journal-title': 'Rheumatol Int'}, { 'key': '5056_CR29', 'doi-asserted-by': 'publisher', 'author': 'W Miesbach', 'year': '2020', 'unstructured': 'Miesbach W, Makris M (2020) COVID-19: coagulopathy, risk of thrombosis, ' 'and the rationale for anticoagulation. Clin Appl Thromb Hemost. ' 'https://doi.org/10.1177/1076029620938149 (PMID: 32677459; PMCID: ' 'PMC7370334)', 'journal-title': 'Clin Appl Thromb Hemost', 'DOI': '10.1177/1076029620938149'}, { 'issue': '3', 'key': '5056_CR30', 'doi-asserted-by': 'publisher', 'first-page': 'e171', 'DOI': '10.1016/S2665-9913(21)00003-5', 'volume': '3', 'author': 'P Mehta', 'year': '2021', 'unstructured': 'Mehta P, Haskard DO, Laffan MA, Chambers RC, Hunt BJ (2021) Thromboses ' 'and COVID-19: reducing inflammation in addition to thromboprophylaxis. ' 'Lancet Rheumatol. 3(3):e171–e172. ' 'https://doi.org/10.1016/S2665-9913(21)00003-5 (Epub 2021 Jan 7. PMID: ' '33521654; PMCID: PMC7832098)', 'journal-title': 'Lancet Rheumatol.'}, { 'issue': '9', 'key': '5056_CR31', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pmed.1003379', 'volume': '17', 'author': 'CT Rentsch', 'year': '2020', 'unstructured': 'Rentsch CT, Kidwai-Khan F, Tate JP, Park LS, King JT Jr, Skanderson M, ' 'Hauser RG, Schultze A, Jarvis CI, Holodniy M, Lo RV 3rd, Akgün KM, ' 'Crothers K, Taddei TH, Freiberg MS, Justice AC (2020) Patterns of ' 'COVID-19 testing and mortality by race and ethnicity among United States ' 'veterans: a nationwide cohort study. PLoS Med. 17(9):e1003379. ' 'https://doi.org/10.1371/journal.pmed.1003379 (PMID: 32960880; PMCID: ' 'PMC7508372)', 'journal-title': 'PLoS Med.'}, { 'issue': '12', 'key': '5056_CR32', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0243414', 'volume': '15', 'author': 'JA Trubiano', 'year': '2020', 'unstructured': 'Trubiano JA, Vogrin S, Smibert OC, Marhoon N, Alexander AA, Chua KYL, ' 'James FL, Jones NRL, Grigg SE, Xu CLH, Moini N, Stanley SR, Birrell MT, ' 'Rose MT, Gordon CL, Kwong JC, Holmes NE (2020) COVID-MATCH65-A ' 'prospectively derived clinical decision rule for severe acute ' 'respiratory syndrome coronavirus 2. PLoS ONE 15(12):e0243414. ' 'https://doi.org/10.1371/journal.pone.0243414', 'journal-title': 'PLoS ONE'}, { 'issue': '6', 'key': '5056_CR33', 'doi-asserted-by': 'publisher', 'first-page': '1319', 'DOI': '10.1111/add.15276', 'volume': '116', 'author': 'D Simons', 'year': '2021', 'unstructured': 'Simons D, Shahab L, Brown J, Perski O (2021) The association of smoking ' 'status with SARS-CoV-2 infection, hospitalization and mortality from ' 'COVID-19: a living rapid evidence review with Bayesian meta-analyses ' '(version 7). Addiction 116(6):1319–1368. ' 'https://doi.org/10.1111/add.15276', 'journal-title': 'Addiction'}, { 'key': '5056_CR34', 'doi-asserted-by': 'publisher', 'author': 'P Tsigaris', 'year': '2020', 'unstructured': 'Tsigaris P, Teixeira da Silva JA (2020) Smoking Prevalence and COVID-19 ' 'in Europe. Nicotine Tob Res. https://doi.org/10.1093/ntr/ntaa121', 'journal-title': 'Nicotine Tob Res', 'DOI': '10.1093/ntr/ntaa121'}, { 'issue': '20', 'key': '5056_CR35', 'doi-asserted-by': 'publisher', 'first-page': '7394', 'DOI': '10.3390/ijerph17207394', 'volume': '17', 'author': 'J González-Rubio', 'year': '2020', 'unstructured': 'González-Rubio J, Navarro-López C, López-Nájera E, López-Nájera A, ' 'Jiménez-Díaz L, Navarro-López JD, Nájera A (2020) A systematic review ' 'and meta-analysis of hospitalised current smokers and COVID-19. Int J ' 'Environ Res Public Health 17(20):7394. ' 'https://doi.org/10.3390/ijerph17207394', 'journal-title': 'Int J Environ Res Public Health'}, { 'issue': '11', 'key': '5056_CR36', 'doi-asserted-by': 'publisher', 'first-page': '204062232093576', 'DOI': '10.1177/2040622320935765', 'volume': '25', 'author': 'K Farsalinos', 'year': '2020', 'unstructured': 'Farsalinos K, Barbouni A, Poulas K, Polosa R, Caponnetto P, Niaura R ' '(2020) Current smoking, former smoking, and adverse outcome among ' 'hospitalized COVID-19 patients: a systematic review and meta-analysis. ' 'Ther Adv Chronic Dis 25(11):2040622320935765. ' 'https://doi.org/10.1177/2040622320935765', 'journal-title': 'Ther Adv Chronic Dis'}, { 'issue': '6', 'key': '5056_CR37', 'doi-asserted-by': 'publisher', 'first-page': '2001340', 'DOI': '10.1183/13993003.01340-2020', 'volume': '55', 'author': 'JM Leung', 'year': '2020', 'unstructured': 'Leung JM, Yang CX, Sin DD (2020) Reply to: “Current smoking is not ' 'associated with COVID-19.” Eur Respir J 55(6):2001340. ' 'https://doi.org/10.1183/13993003.01340-2020', 'journal-title': 'Eur Respir J'}, { 'issue': '2', 'key': '5056_CR38', 'doi-asserted-by': 'publisher', 'first-page': '1045', 'DOI': '10.1002/jmv.26389', 'volume': '93', 'author': 'RK Reddy', 'year': '2021', 'unstructured': 'Reddy RK, Charles WN, Sklavounos A, Dutt A, Seed PT, Khajuria A (2021) ' 'The effect of smoking on COVID-19 severity: a systematic review and ' 'meta-analysis. J Med Virol 93(2):1045–1056. ' 'https://doi.org/10.1002/jmv.26389', 'journal-title': 'J Med Virol'}, { 'issue': '9', 'key': '5056_CR39', 'doi-asserted-by': 'publisher', 'first-page': '1653', 'DOI': '10.1093/ntr/ntaa082', 'volume': '22', 'author': 'R Patanavanich', 'year': '2020', 'unstructured': 'Patanavanich R, Glantz SA (2020) Smoking is associated With COVID-19 ' 'progression: a meta-analysis. Nicotine Tob Res 22(9):1653–1656. ' 'https://doi.org/10.1093/ntr/ntaa082', 'journal-title': 'Nicotine Tob Res'}, { 'issue': '8', 'key': '5056_CR40', 'doi-asserted-by': 'publisher', 'first-page': '825', 'DOI': '10.1136/thx.49.8.825', 'volume': '49', 'author': 'JA Dye', 'year': '1994', 'unstructured': 'Dye JA, Adler KB (1994) Effects of cigarette smoke on epithelial cells ' 'of the respiratory tract. Thorax 49(8):825–834. ' 'https://doi.org/10.1136/thx.49.8.825', 'journal-title': 'Thorax'}, { 'issue': '6', 'key': '5056_CR41', 'doi-asserted-by': 'publisher', 'first-page': '2001116', 'DOI': '10.1183/13993003.01116-2020', 'volume': '55', 'author': 'P Russo', 'year': '2020', 'unstructured': 'Russo P, Bonassi S, Giacconi R, Malavolta M, Tomino C, Maggi F (2020) ' 'COVID-19 and smoking: is nicotine the hidden link? Eur Respir J ' '55(6):2001116. https://doi.org/10.1183/13993003.01116-2020', 'journal-title': 'Eur Respir J'}, { 'issue': '10', 'key': '5056_CR42', 'doi-asserted-by': 'publisher', 'first-page': '575', 'DOI': '10.12968/hmed.2008.69.10.31317', 'volume': '69', 'author': 'DS Yang', 'year': '2008', 'unstructured': 'Yang DS, Taylor SR, Lightman SL (2008) Interferon-alpha in the ' 'management of patients with Behçet’s disease. Br J Hosp Med (Lond) ' '69(10):575–579. https://doi.org/10.12968/hmed.2008.69.10.31317', 'journal-title': 'Br J Hosp Med (Lond)'}, { 'issue': '3', 'key': '5056_CR43', 'first-page': '255', 'volume': '1', 'author': 'L Lai', 'year': '2006', 'unstructured': 'Lai L, Hui CK, Leung N, Lau GK (2006) Pegylated interferon alpha-2a (40 ' 'kDa) in the treatment of chronic hepatitis B. Int J Nanomedicine. ' '1(3):255–62 (PMID: 17717966; PMCID: PMC2426802)', 'journal-title': 'Int J Nanomedicine.'}, { 'issue': '4', 'key': '5056_CR44', 'doi-asserted-by': 'publisher', 'first-page': '429', 'DOI': '10.1016/j.bpg.2012.09.013', 'volume': '26', 'author': 'JJ Feld', 'year': '2012', 'unstructured': 'Feld JJ (2012) Treatment indication and response to standard of care ' 'with peginterferon and ribavirin in acute and chronic HCV infection. ' 'Best Pract Res Clin Gastroenterol 26(4):429–444. ' 'https://doi.org/10.1016/j.bpg.2012.09.013', 'journal-title': 'Best Pract Res Clin Gastroenterol'}, { 'issue': '11', 'key': '5056_CR45', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fimmu.2020.615275.Erratumfor:FrontImmunol.2020May15;11:1061', 'volume': '27', 'author': 'Q Zhou', 'year': '2020', 'unstructured': 'Zhou Q, Chen V, Shannon CP, Wei XS, Xiang X, Wang X, Wang ZH, Tebbutt ' 'SJ, Kollmann TR, Fish EN (2020) Corrigendum: interferon-α2b treatment ' 'for COVID-19. Front Immunol 27(11):615275. ' 'https://doi.org/10.3389/fimmu.2020.615275.Erratumfor:FrontImmunol.2020May15;11:1061', 'journal-title': 'Front Immunol'}, { 'issue': '24', 'key': '5056_CR46', 'doi-asserted-by': 'publisher', 'first-page': '3222', 'DOI': '10.1001/jama.290.24.3222', 'volume': '290', 'author': 'MR Loutfy', 'year': '2003', 'unstructured': 'Loutfy MR, Blatt LM, Siminovitch KA, Ward S, Wolff B, Lho H, Pham DH, ' 'Deif H, LaMere EA, Chang M, Kain KC, Farcas GA, Ferguson P, Latchford M, ' 'Levy G, Dennis JW, Lai EK, Fish EN (2003) Interferon alfacon-1 plus ' 'corticosteroids in severe acute respiratory syndrome: a preliminary ' 'study. JAMA 290(24):3222–3228. https://doi.org/10.1001/jama.290.24.3222', 'journal-title': 'JAMA'}, { 'key': '5056_CR47', 'doi-asserted-by': 'publisher', 'author': 'Q Zhang', 'year': '2020', 'unstructured': 'Zhang Q, Bastard P, Liu Z et al (2020) Inborn errors of type I IFN ' 'immunity in patients with life-threatening COVID-19. Science. ' 'https://doi.org/10.1126/science.abd4570', 'journal-title': 'Science.', 'DOI': '10.1126/science.abd4570'}, { 'issue': '6504', 'key': '5056_CR48', 'doi-asserted-by': 'publisher', 'first-page': '718', 'DOI': '10.1126/science.abc6027', 'volume': '369', 'author': 'J Hadjadj', 'year': '2020', 'unstructured': 'Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, ' 'Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit ' 'R, Morbieu C, Pène F, Marin N, Roche N, Szwebel TA, Merkling SH, ' 'Treluyer JM, Veyer D, Mouthon L, Blanc C, Tharaux PL, Rozenberg F, ' 'Fischer A, Duffy D, Rieux-Laucat F, Kernéis S, Terrier B (2020) Impaired ' 'type I interferon activity and inflammatory responses in severe COVID-19 ' 'patients. Science 369(6504):718–724. ' 'https://doi.org/10.1126/science.abc6027', 'journal-title': 'Science'}, { 'issue': '6', 'key': '5056_CR49', 'doi-asserted-by': 'publisher', 'first-page': '659', 'DOI': '10.2174/1381612824666180123110042', 'volume': '24', 'author': 'C Angelidis', 'year': '2018', 'unstructured': 'Angelidis C, Kotsialou Z, Kossyvakis C, Vrettou AR, Zacharoulis A, ' 'Kolokathis F, Kekeris V, Giannopoulos G (2018) Colchicine ' 'Pharmacokinetics and Mechanism of Action. Curr Pharm Des 24(6):659–663. ' 'https://doi.org/10.2174/1381612824666180123110042', 'journal-title': 'Curr Pharm Des'}, { 'issue': '6', 'key': '5056_CR50', 'doi-asserted-by': 'publisher', 'first-page': '503', 'DOI': '10.1016/j.ejim.2010.09.010', 'volume': '21', 'author': 'G Cocco', 'year': '2010', 'unstructured': 'Cocco G, Chu DC, Pandolfi S (2010) Colchicine in clinical medicine. A ' 'guide for internists. Eur J Intern Med. 21(6):503–8. ' 'https://doi.org/10.1016/j.ejim.2010.09.010', 'journal-title': 'Eur J Intern Med.'}, { 'issue': '4', 'key': '5056_CR51', 'doi-asserted-by': 'publisher', 'first-page': '469', 'DOI': '10.1002/cmdc.201800641', 'volume': '14', 'author': 'M Richter', 'year': '2019', 'unstructured': 'Richter M, Boldescu V, Graf D, Streicher F, Dimoglo A, Bartenschlager R, ' 'Klein CD (2019) Synthesis, biological evaluation, and molecular docking ' 'of combretastatin and colchicine derivatives and their hCE1-Activated ' 'Prodrugs as Antiviral Agents. ChemMedChem 14(4):469–483. ' 'https://doi.org/10.1002/cmdc.201800641', 'journal-title': 'ChemMedChem'}, { 'issue': '6', 'key': '5056_CR52', 'doi-asserted-by': 'publisher', 'first-page': '2013136', 'DOI': '10.1001/jamanetworkopen.2020.13136', 'volume': '3', 'author': 'SG Deftereos', 'year': '2020', 'unstructured': 'Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, ' 'Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, ' 'Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis ' 'H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, ' 'Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, ' 'Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, ' 'Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, ' 'Martinèz-Dolz L, Reimers B, Stefanini GG, Cleman M, Goudevenos J, ' 'Tsiodras S, Tousoulis D, Iliodromitis E, Mehran R, Dangas G, Stefanadis ' 'C, GRECCO-19 investigators (2020) Effect of Colchicine vs Standard Care ' 'on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients ' 'Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized ' 'Clinical Trial. JAMA Netw Open. 3(6):2013136. ' 'https://doi.org/10.1001/jamanetworkopen.2020.13136', 'journal-title': 'JAMA Netw Open.'}, { 'issue': '3', 'key': '5056_CR53', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0248276', 'volume': '16', 'author': 'L Manenti', 'year': '2021', 'unstructured': 'Manenti L, Maggiore U, Fiaccadori E, Meschi T, Antoni AD, Nouvenne A, ' 'Ticinesi A, Cerundolo N, Prati B, Delsante M, Gandoflini I, Donghi L, ' 'Gentile M, Farina MT, Oliva V, Zambrano C, Regolisti G, Palmisano A, ' 'Caminiti C, Cocchi E, Ferrari C, Riella LV, Cravedi P, Peruzzi L (2021) ' 'Reduced mortality in COVID-19 patients treated with colchicine: results ' 'from a retrospective, observational study. PLoS ONE 16(3):e0248276. ' 'https://doi.org/10.1371/journal.pone.0248276', 'journal-title': 'PLoS ONE'}, { 'issue': '1', 'key': '5056_CR54', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/rmdopen-2020-001455', 'volume': '7', 'author': 'MI Lopes', 'year': '2021', 'unstructured': 'Lopes MI, Bonjorno LP, Giannini MC, Amaral NB, Menezes PI, Dib SM, ' 'Gigante SL, Benatti MN, Rezek UC, Emrich-Filho LL, Sousa BAA, Almeida ' 'SCL, Luppino Assad R, Veras FP, Schneider A, Rodrigues TS, Leiria LOS, ' 'Cunha LD, Alves-Filho JC, Cunha TM, Arruda E, Miranda CH, Pazin-Filho A, ' 'Auxiliadora-Martins M, Borges MC, Fonseca BAL, Bollela VR, Del-Ben CM, ' 'Cunha FQ, Zamboni DS, Santana RC, Vilar FC, Louzada-Junior P, Oliveira ' 'RDR (2021) Beneficial effects of colchicine for moderate to severe ' 'COVID-19: a randomised, double-blinded, placebo-controlled clinical ' 'trial. RMD Open 7(1):e001455. ' 'https://doi.org/10.1136/rmdopen-2020-001455', 'journal-title': 'RMD Open'}, { 'issue': '8', 'key': '5056_CR55', 'doi-asserted-by': 'publisher', 'first-page': '924', 'DOI': '10.1016/S2213-2600(21)00222-8', 'volume': '9', 'author': 'JC Tardif', 'year': '2021', 'unstructured': 'Tardif JC, Bouabdallaoui N, L’Allier PL, Gaudet D, Shah B, Pillinger MH, ' 'Lopez-Sendon J, da Luz P, Verret L, Audet S, Dupuis J, Denault A, ' 'Pelletier M, Tessier PA, Samson S, Fortin D, Tardif JD, Busseuil D, ' 'Goulet E, Lacoste C, Dubois A, Joshi AY, Waters DD, Hsue P, Lepor NE, ' 'Lesage F, Sainturet N, Roy-Clavel E, Bassevitch Z, Orfanos A, Stamatescu ' 'G, Grégoire JC, Busque L, Lavallée C, Hétu PO, Paquette JS, Deftereos ' 'SG, Levesque S, Cossette M, Nozza A, Chabot-Blanchet M, Dubé MP, Guertin ' 'MC, Boivin G, COLCORONA Investigators (2021) Colchicine for ' 'community-treated patients with COVID-19 (COLCORONA): a phase 3, ' 'randomised, double-blinded, adaptive, placebo-controlled, multicentre ' 'trial. Lancet Respir Med. 9(8):924–932. ' 'https://doi.org/10.1016/S2213-2600(21)00222-8', 'journal-title': 'Lancet Respir Med.'}, { 'issue': '7', 'key': '5056_CR56', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.autrev.2020.102566', 'volume': '19', 'author': 'O Gendelman', 'year': '2020', 'unstructured': 'Gendelman O, Amital H, Bragazzi NL, Watad A, Chodick G (2020) Continuous ' 'hydroxychloroquine or colchicine therapy does not prevent infection with ' 'SARS-CoV-2: Insights from a large healthcare database analysis. ' 'Autoimmun Rev 19(7):102566. https://doi.org/10.1016/j.autrev.2020.102566', 'journal-title': 'Autoimmun Rev'}, { 'key': '5056_CR57', 'doi-asserted-by': 'publisher', 'author': 'A Madrid-García', 'year': '2021', 'unstructured': 'Madrid-García A, Pérez I, Colomer JI, León-Mateos L, Jover JA, ' 'Fernández-Gutiérrez B, Abásolo-Alcazar L, Rodríguez-Rodríguez L (2021) ' 'Influence of colchicine prescription in COVID-19-related hospital ' 'admissions: a survival analysis. Ther Adv Musculoskelet Dis. ' 'https://doi.org/10.1177/1759720X211002684', 'journal-title': 'Ther Adv Musculoskelet Dis.', 'DOI': '10.1177/1759720X211002684'}, { 'issue': '4', 'key': '5056_CR58', 'doi-asserted-by': 'publisher', 'first-page': '811', 'DOI': '10.1007/s00296-021-04809-3', 'volume': '41', 'author': 'K Nas', 'year': '2021', 'unstructured': 'Nas K, Eryilmaz N, Geyik MF, Altaş A (2021) COVID-19 in patients with ' 'familial Mediterranean fever treated with colchicine: case based review. ' 'Rheumatol Int 41(4):811–817. https://doi.org/10.1007/s00296-021-04809-3', 'journal-title': 'Rheumatol Int'}, { 'key': '5056_CR59', 'doi-asserted-by': 'publisher', 'author': 'R Bourguiba', 'year': '2020', 'unstructured': 'Bourguiba R, Delplanque M, Vinit C, Ackermann F, Savey L, Grateau G, ' 'Hentgen V, Georgin-Lavialle S (2020) Clinical course of COVID-19 in a ' 'cohort of 342 familial Mediterranean fever patients with a long-term ' 'treatment by colchicine in a French endemic area. Ann Rheum Dis. ' 'https://doi.org/10.1136/annrheumdis-2020-218707', 'journal-title': 'Ann Rheum Dis', 'DOI': '10.1136/annrheumdis-2020-218707'}, { 'issue': '2', 'key': '5056_CR60', 'doi-asserted-by': 'publisher', 'first-page': '71', 'DOI': '10.1038/s41584-020-00562-2.PMID:33339986;PMCID:PMC7747184', 'volume': '17', 'author': 'KL Hyrich', 'year': '2021', 'unstructured': 'Hyrich KL, Machado PM (2021) Rheumatic disease and COVID-19: ' 'epidemiology and outcomes. Nat Rev Rheumatol 17(2):71–72. ' 'https://doi.org/10.1038/s41584-020-00562-2.PMID:33339986;PMCID:PMC7747184', 'journal-title': 'Nat Rev Rheumatol'}, { 'issue': '5', 'key': '5056_CR61', 'doi-asserted-by': 'publisher', 'first-page': '533', 'DOI': '10.1007/s00038-020-01390-7', 'volume': '65', 'author': 'V Jain', 'year': '2020', 'unstructured': 'Jain V, Yuan JM (2020) Predictive symptoms and comorbidities for severe ' 'COVID-19 and intensive care unit admission: a systematic review and ' 'meta-analysis. Int J Public Health 65(5):533–546. ' 'https://doi.org/10.1007/s00038-020-01390-7', 'journal-title': 'Int J Public Health'}], 'container-title': 'Rheumatology International', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s00296-021-05056-2.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s00296-021-05056-2/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s00296-021-05056-2.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2023, 1, 16]], 'date-time': '2023-01-16T08:33:32Z', 'timestamp': 1673858012000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s00296-021-05056-2'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 11, 25]]}, 'references-count': 61, 'journal-issue': {'issue': '1', 'published-print': {'date-parts': [[2022, 1]]}}, 'alternative-id': ['5056'], 'URL': 'http://dx.doi.org/10.1007/s00296-021-05056-2', 'relation': {}, 'ISSN': ['0172-8172', '1437-160X'], 'subject': ['Immunology', 'Immunology and Allergy', 'Rheumatology'], 'container-title-short': 'Rheumatol Int', 'published': {'date-parts': [[2021, 11, 25]]}, 'assertion': [ { 'value': '21 October 2021', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '13 November 2021', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '25 November 2021', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'Guzin Ozcifci, Tahacan Aydin, Zeynep Atli, Ilker Inanc Balkan, Mert Oztas, ' 'Yesim Ozguler, Melike Melikoglu, Izzet Fresko and Vedat Hamuryudan declare that ' 'they have no conflict of interest. Fehmi Tabak, has received honoraria, ' 'consulting or speaker fees from GSK, MSD, AbbVie and Gilead. Serdal Ugurlu has ' 'received honoraria, consulting or speaker fees from Novartis, Pfizer, Lilly and ' 'Celltrion. Gulen Hatemi has received research grant from Celgene, honoraria ' 'consulting or speaker fees from AbbVie, Amgen, Celgene, Lilly, Novartis and UCB ' 'Pharma. Emire Seyahi has received honoraria, consulting or speaker fees from ' 'Novartis, Pfizer, AbbVie and Gilead.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Conflict of interest'}}, { 'value': 'This content has been made available to all.', 'name': 'free', 'label': 'Free to read'}]}